Aura Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €125.68M +63.8% -€53.80M -36.4% -42.8% +0.67 pp N/A N/A
    (estimated) €76.73M +210.6% -€84.60M -23.8% -110.3% +3.4 pp N/A N/A
    (estimated) €24.70M +∞% -€111.00M -1.7% -449.4% -4.5 pp N/A N/A
    (estimated) €0.00 +NaN% -€112.88M +15.6% N/A N/A N/A
    (estimated) €0.00 +NaN% -€97.62M +30.4% N/A N/A N/A
    €0.00 +NaN% -€74.88M +13.8% N/A -€67.68M +24.4% N/A
    €0.00 +NaN% -€65.83M +33.5% N/A -€54.40M +18.0% N/A
    €0.00 +NaN% -€49.31M +66.3% N/A -€46.10M +76.7% N/A
    €0.00 +NaN% -€29.66M +55.0% N/A -€26.09M +28.6% N/A
    €0.00 +NaN% -€19.13M -8.2% N/A -€20.29M +27.7% N/A
    €0.00 -€20.85M N/A -€15.89M N/A

    Notifications